PMV Pharmaceuticals
A Doylestown, Penn-based developer of p53-targeted small molecule drugs for the treatment of cancer.
HQ location
Cranbury Township, United States
Website
Launch date
Employees
Market cap
$55.6m
Authorizing premium user...
A Doylestown, Penn-based developer of p53-targeted small molecule drugs for the treatment of cancer.